天韻國際(06836.HK)與馬來西亞熱帶水果生產商Tuah Tacunan達成戰略合作
天韻國際(06836.HK)公佈,近日馬來西亞熱帶水果生產商Tuah Tacunan,於熱帶水果銷售及水果加工方面達成戰略合作。
根據協議,雙方將建立新鮮熱帶水果及上下遊供應鏈系統,同時集團亦將積極協助Tuan Tachunan於馬來西亞沙巴州的農田發展熱帶特色水果種植,建立水果加工產品生產基地,並將其部份新鮮水果,引入至集團現有水果加工產品體系當中。
天韻國際表示,Tuah Tacunan位於沙巴洲的生產基地享有優越的自然條件和地理位置,並受惠於RCEP關稅優惠,預料可協助集團發展熱帶鮮銷水果貿易,增強企業競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.